US › Healthcare

Onconetix Inc (ONCO)

US · Healthcare · Biotechnology

$0.48-12.59%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$17,120

Revenue YoY

-83.9%

Net profit

$-2.9M

EPS

$-1.28

Net margin

-16,748.3%

Key statistics

Market cap

$3.2M

P/E

0.0

Forward P/E

0.0

P/B

0.22

Book value

$3.55

EPS (TTM)

$295.93

52-week high

$200.00

52-week low

$0.58

50-day MA

$0.76

200-day MA

$19.83

Beta

2.61

Analyst view

with an average price target of $9.00.

Shareholding

Insiders

0.13%

Institutions

5.52%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.98%
XTX Topco Ltd	0.26%
SBI Securities Co Ltd	0.00%
Tower Research Capital LLC	0.00%
Hollencrest Securities, LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
DRW Securities, LLC	0.00%
Danske Bank A/S.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Onconetix Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.